TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Campus Pharma AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
170,500
|
140,953
|
116,994 |
| Financial expenses |
422
|
904
|
799 |
| Earnings before taxes |
18,925
|
-3,419
|
-6,325 |
| EBITDA |
29,478
|
15,060
|
11,647 |
| Total assets |
72,872
|
89,527
|
79,788 |
| Current assets |
68,680
|
72,338
|
47,552 |
| Current liabilities |
41,183
|
46,829
|
34,190 |
| Equity capital |
31,649
|
42,022
|
45,598 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
43
|
38
|
30 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.4%
|
46.9%
|
57.1% |
| Turnover per employee |
3,965
|
3,709
|
3,900 |
| Profit as a percentage of turnover |
11.1%
|
-2.4%
|
-5.4% |
| Return on assets (ROA) |
26.5%
|
-2.8%
|
-6.9% |
| Current ratio |
166.8%
|
154.5%
|
139.1% |
| Return on equity (ROE) |
59.8%
|
-8.1%
|
-13.9% |
| Change turnover |
34,210
|
23,357
|
4,495 |
| Change turnover % |
25%
|
20%
|
4% |
| Chg. No. of employees |
5
|
8
|
3 |
| Chg. No. of employees % |
13%
|
27%
|
11% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.